Kulbay M, Tuli N, Mazza M, Jaffer A, Juntipwong S, Marcotte E
Biomedicines. 2025; 13(1).
PMID: 39857692
PMC: 11762644.
DOI: 10.3390/biomedicines13010108.
Zebret S, Hadiji M, Romano-deGea J, Bornet A, Ortiz D, Fadaei-Tirani F
RSC Med Chem. 2024; 15(7):2300-2304.
PMID: 39026655
PMC: 11253858.
DOI: 10.1039/d4md00211c.
Muniyandi A, Jensen N, Devanathan N, Dimaras H, Corson T
Invest Ophthalmol Vis Sci. 2024; 65(1):18.
PMID: 38180770
PMC: 10774694.
DOI: 10.1167/iovs.65.1.18.
Alahmadi G, Maktabi A, Sesma G, AlMesfer S
Clin Ophthalmol. 2023; 17:1789-1800.
PMID: 37377999
PMC: 10292623.
DOI: 10.2147/OPTH.S417370.
Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F
Onco Targets Ther. 2022; 15:1545-1561.
PMID: 36579184
PMC: 9792108.
DOI: 10.2147/OTT.S370878.
Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
Riazi-Esfahani H, Masoomian B, Khodabandeh A, Amini A, Taghizadeh S, Boujabadi L
Graefes Arch Clin Exp Ophthalmol. 2022; 261(4):1167-1175.
PMID: 36401651
DOI: 10.1007/s00417-022-05903-3.
Early Mechanisms of Chemoresistance in Retinoblastoma.
Zhang M, Kuznetsoff J, Owens D, Gallo R, Kalahasty K, Cruz A
Cancers (Basel). 2022; 14(19).
PMID: 36230889
PMC: 9563111.
DOI: 10.3390/cancers14194966.
ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection.
Albuquerque M, Moreto R, Bergamo M, Correa Z, Jorge R
Arq Bras Oftalmol. 2022; 87(1):0037.
PMID: 35857974
PMC: 11606518.
DOI: 10.5935/0004-2749.2021-0037.
Treatment of Retinoblastoma: What Is the Latest and What Is the Future.
Schaiquevich P, Francis J, Cancela M, Montero Carcaboso A, Chantada G, Abramson D
Front Oncol. 2022; 12:822330.
PMID: 35433448
PMC: 9010858.
DOI: 10.3389/fonc.2022.822330.
Combination of Brachytherapy and Intravitreal Chemotherapy in the Treatment of Retinoblastoma with Vitreous Seeding.
Schluter S, Bornfeld N, Valiyev E, Fluhs D, Stuschke M, Bechrakis N
Ocul Oncol Pathol. 2022; 8(1):64-70.
PMID: 35356603
PMC: 8914268.
DOI: 10.1159/000520952.
Intravitreal melphalan for persistent retinoblastoma vitreous seeds.
Redondo-Villanueva M, Mercado G
GMS Ophthalmol Cases. 2022; 12:Doc03.
PMID: 35291586
PMC: 8900198.
DOI: 10.3205/oc000190.
Pars plana vitrectomy for vitreoretinal complications in only seeing eyes after treatment for retinoblastoma.
Nishida K, Morimoto T, Suzuki S, Iwahashi C, Imai H, Kuniyoshi K
Am J Ophthalmol Case Rep. 2022; 25:101367.
PMID: 35243141
PMC: 8859804.
DOI: 10.1016/j.ajoc.2022.101367.
The Results of Pars Plana Vitrectomy in the Treatment of Intraocular Retinoblastoma: A Retrospective Study and Literature Review.
Li L, He T, Su Y, Wu L, Chen C
Technol Cancer Res Treat. 2021; 20:15330338211048634.
PMID: 34747279
PMC: 8573478.
DOI: 10.1177/15330338211048634.
Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma.
Yousef Y, Al Jboor M, Mohammad M, Mehyar M, Toro M, Nazzal R
Front Pharmacol. 2021; 12:696787.
PMID: 34322023
PMC: 8311556.
DOI: 10.3389/fphar.2021.696787.
Commentary: Retinoblastoma management-Where are we and where do we go from here?.
Shanmugam P
Indian J Ophthalmol. 2020; 68(11):2365-2366.
PMID: 33120617
PMC: 7774233.
DOI: 10.4103/ijo.IJO_1954_20.
Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.
Yu X, Li X, Xing Y, Lu S, Tanumiharjo S, Ma J
BMC Cancer. 2020; 20(1):808.
PMID: 32847550
PMC: 7448309.
DOI: 10.1186/s12885-020-07314-1.
Retinoblastoma: Etiology, Modeling, and Treatment.
Kaewkhaw R, Rojanaporn D
Cancers (Basel). 2020; 12(8).
PMID: 32824373
PMC: 7465685.
DOI: 10.3390/cancers12082304.
Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma.
Yousef Y, Noureldin A, Sultan I, Deebajah R, Al-Hussaini M, Shawagfeh M
J Ophthalmol. 2020; 2020:8628525.
PMID: 32047663
PMC: 7003283.
DOI: 10.1155/2020/8628525.
Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6.
Yang Y, Wu N, Wu Y, Chen H, Qiu J, Qian X
Cell Death Dis. 2019; 10(11):862.
PMID: 31723124
PMC: 6853908.
DOI: 10.1038/s41419-019-2084-1.
Intra-arterial chemotherapy in retinoblastoma - A paradigm change.
Manjandavida F, Stathopoulos C, Zhang J, Honavar S, Shields C
Indian J Ophthalmol. 2019; 67(6):740-754.
PMID: 31124482
PMC: 6552585.
DOI: 10.4103/ijo.IJO_866_19.